Drug Profile
Research programme: paediatric malaria vaccine - Crucell/PRIBOMAL
Latest Information Update: 20 Jun 2011
Price :
$50
*
At a glance
- Originator Crucell
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 20 Jun 2011 No development reported - Preclinical for Malaria in Netherlands (Parenteral)
- 30 Jan 2007 Preclinical trials in Malaria in Netherlands (Injection)